Zobrazeno 1 - 10
of 14
pro vyhledávání: '"M. E. Telnova"'
The place of gliclazide MB in modern treatment strategies for patients with type 2 diabetes mellitus
Autor:
N. A. Petunina, N. S. Martirosian, E. V. Goncharova, M. E. Telnova, I. A. Kuzina, A. O. Shchetinina, E. A. Elmurzaeva
Publikováno v:
Сахарный диабет, Vol 27, Iss 4, Pp 368-375 (2024)
Sulfonylurea (SU) are an effective class of oral hypoglycemic drugs that have been used in clinical practice for more than 70 years. Despite the common mechanism of action, members of the class have significant intraclass differences in hypoglycemic
Externí odkaz:
https://doaj.org/article/1ed28c6b6e6c439796524f323a8b91a5
Publikováno v:
Медицинский совет, Vol 0, Iss 12, Pp 305-310 (2021)
Sodium-glucose cotransporter-2 inhibitors are the new drugs for the treatment of type 2 diabetes mellitus. Its mechanism of action is to increase the excretion of glucose in the urine due to inhibition of reabsorption in the proximal renal tubules, w
Externí odkaz:
https://doaj.org/article/3cc0e424aec843b6b4a728e8a0bdd16d
Publikováno v:
Медицинский совет, Vol 0, Iss 21, Pp 214-218 (2020)
For many years, interest in the issue of obesity has not faded, as obesity is now one of the most common pathologies in the world that directly affects quality of life and lifespan. Even a slight weight loss (5-10% of baseline values) in obese patien
Externí odkaz:
https://doaj.org/article/00972f45ad4440928dc7b48d83596957
Publikováno v:
Медицинский совет, Vol 0, Iss 4, Pp 14-19 (2019)
The prevalence of T2D is steadily increasing annually, which resulted in an active search for a way to control the disease. The last decade has seen a rise in the number of new groups of glucose-lowering drugs, which not only proved effective in the
Externí odkaz:
https://doaj.org/article/175d300b5d22404a80d15d189248a43e
Autor:
N A Petunina, M E Telnova
Publikováno v:
Гинекология, Vol 18, Iss 4, Pp 45-48 (2016)
The article presents data on the current state of the problem of iodine deficiency, as well as negative impact of iodine deficiency on the health of pregnant women and children, covering methods of iodine prophylaxis.
Externí odkaz:
https://doaj.org/article/d997c28e1c364355976a1ec2ac27013b
Publikováno v:
Effective Pharmacotherapy. 16:16-24
Publikováno v:
Медицинский совет, Vol 0, Iss 4, Pp 14-19 (2019)
The prevalence of T2D is steadily increasing annually, which resulted in an active search for a way to control the disease. The last decade has seen a rise in the number of new groups of glucose-lowering drugs, which not only proved effective in the
Autor:
N. A. Petunina, M. E. Telnova
Publikováno v:
Clinical Medicine (Russian Journal). 95:829-835
Aim. To study metabolic-hormonal status and psychological characteristics of young obese men. Material and methods. The study included 87 young obese men (BMI ≥30 kg/m2) aged 16-25 yr given medication or non-medication treatment for 12 weeks. Blood
Autor:
M E Telnova, N. A. Petunina
Publikováno v:
Гинекология, Vol 18, Iss 4, Pp 45-48 (2016)
The article presents data on the current state of the problem of iodine deficiency, as well as negative impact of iodine deficiency on the health of pregnant women and children, covering methods of iodine prophylaxis.
Autor:
N. A. Petunina, M. E. Telnova, Zoya Ivanovna Levitskaya, L. V. Trukhina, Lyudmila Viktorovna Nedosugova
Publikováno v:
Сахарный диабет, Vol 17, Iss 3, Pp 134-138 (2014)
We introduce the audience to the personal and professional life of M.I. Balabolkin ? a prominent Russian endocrinologist, scientist and a proliferous author. We highlight his contribution into the development of national endocrinology services, inclu